An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer's disease.
Kizuka Y, Kitazume S, Fujinawa R, Saito T, Iwata N, Saido TC, Nakano M, Yamaguchi Y, Hashimoto Y, Staufenbiel M, Hatsuta H, Murayama S, Manya H, Endo T, Taniguchi N.
Kizuka Y, et al.
EMBO Mol Med. 2015 Feb;7(2):175-89. doi: 10.15252/emmm.201404438.
EMBO Mol Med. 2015.
PMID: 25592972
Free PMC article.